Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.
Caméléna F, Mérimèche M, Brousseau J, Mainardis M, Verger P, Le Risbé C, Brottet E, Thabuis A, Bébéar C, Molina JM, Lot F, Chazelle E, Berçot B. Caméléna F, et al. Among authors: molina jm. Emerg Infect Dis. 2024 Sep;30(9):1903-1906. doi: 10.3201/eid3009.240557. Epub 2024 Jul 31. Emerg Infect Dis. 2024. PMID: 39084693 Free PMC article.
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C; OPTIPRIM ANRS Study Group. Chéret A, et al. Among authors: molina jm. Lancet Infect Dis. 2015 Apr;15(4):387-96. doi: 10.1016/S1473-3099(15)70021-6. Epub 2015 Feb 18. Lancet Infect Dis. 2015. PMID: 25701561 Clinical Trial.
Monkeypox clade IIb in France in 2023-2024.
Rahi M, Fouere S, Gilbert M, Bachelard A, Taieb F, Sellem B, Herms F, Cazanave C, Valin N, Monsel G, Yazdanpanah Y, Ghosn J, Peiffer-Smadja N; MPV 23-24 Study group. Rahi M, et al. Lancet Reg Health Eur. 2024 Oct 25;47:101114. doi: 10.1016/j.lanepe.2024.101114. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39526296 Free PMC article. No abstract available.
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multi-Drug Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.
Ogbuagu O, Molina JM, Chetchotisakd P, Ramgopal MN, Sanchez W, Brunetta J, Castelli F, Crofoot GE, Hung CC, Ronot-Bregigeon S, Margot NA, Wang H, Dvory-Sobol H, Rhee MS, Segal-Maurer S. Ogbuagu O, et al. Among authors: molina jm. Clin Infect Dis. 2024 Aug 29:ciae423. doi: 10.1093/cid/ciae423. Online ahead of print. Clin Infect Dis. 2024. PMID: 39206943
Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial.
Ghosn J, Assoumou L, Ouattara M, Rubenstein E, Pialoux G, Katlama C, Surgers L, Duvivier C, Pavie J, Viard JP, Algarte-Genin M, Gibowski S, Ollivier M, Costagliola D, Molina JM. Ghosn J, et al. Among authors: molina jm. Lancet Reg Health Eur. 2024 Aug 1;45:101020. doi: 10.1016/j.lanepe.2024.101020. eCollection 2024 Oct. Lancet Reg Health Eur. 2024. PMID: 39188858 Free PMC article.
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Mayer SA, Bruder N, Citerio G, Defreyne L, Dubois C, Gupta R, Higashida R, Marr A, Nguyen TN, Roux S, Smrčka M, Torné RT, Aldrich EF; on behalf of the REACT investigators. Mayer SA, et al. J Neurosurg. 2024 Aug 9:1-12. doi: 10.3171/2024.4.JNS232191. Online ahead of print. J Neurosurg. 2024. PMID: 39126720
949 results